ICD-11 · 6C42

Disorders due to use of synthetic cannabinoids

Disorders arising from use of synthetic cannabinoids (e.g. "spice"), characterized by loss of control over use, craving, tolerance, withdrawal, and continued use despite harm.

Symptoms

ICD-11 diagnostic criteria

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Disorders due to use of synthetic cannabinoids are:

Differential diagnosis

When diagnosing Disorders due to use of synthetic cannabinoids, the following ICD-11 disorders should be considered in the differential diagnosis:

Synonyms and related terms

Loss of control over use of synthetic cannabinoids, lack of control over synthetic cannabinoids, Strong craving for synthetic cannabinoids, craving for synthetic cannabinoids, Synthetic cannabinoid tolerance, increased substance tolerance, Synthetic cannabinoid withdrawal symptoms, synthetic cannabinoid abstinence symptoms, continued use despite harm, use despite health problems

Frequently asked questions

What are the symptoms of Disorders due to use of synthetic cannabinoids?

Symptoms associated with Disorders due to use of synthetic cannabinoids (ICD-11 6C42) include: Loss of control over amount and frequency of use, Strong craving for the substance, Tolerance (diminishing effect at same dose), Withdrawal symptoms, Use despite health damage.

How is Disorders due to use of synthetic cannabinoids diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Disorders due to use of synthetic cannabinoids (6C42) include: zaburzenie związane z używaniem syntetycznych kannabinoidów; szkody zdrowotne lub behawioralne wynikające z używania syntetycznych kannabinoidów.

What disorders are in the differential diagnosis of Disorders due to use of synthetic cannabinoids?

The differential diagnosis of Disorders due to use of synthetic cannabinoids (6C42) includes: Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41), Zespół odstawienny związany ze stosowaniem cannabis (6C41.4), Majaczenie związane ze stosowaniem cannabis (6C41.5), Zaburzenie psychotyczne wywołane przez cannabis (6C41.6), Niektóre określone zaburzenia psychiczne lub behawioralne wywołane przez cannabis (6C41.7), Zaburzenie nastroju wywołane przez cannabis (6C41.70), Zaburzenie lękowe wywołane przez cannabis (6C41.71), Inne określone zaburzenia spowodowane używaniem kannabinoidów pochodzenia roślinnego (6C41.Y), Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego, nieokreślone (6C41.Z).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C42 – WHO ICD-11

Open in interactive browser →
Source: WHO ICD-11 (chapter 6 – Mental, behavioral and neurodevelopmental disorders). Used under CC BY-ND 3.0 IGO. ICD Diagnostica is not affiliated with or endorsed by WHO. Informational use only – does not replace clinical judgment.